Clinical Trials Directory

Trials / Sponsors / Neothetics, Inc

Neothetics, Inc

Industry · 11 registered clinical trials.

StatusTrialPhaseStarted
CompletedStudy to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat
Submental Fat
Phase 22016-12-22
CompletedSafety and Efficacy Study of LIPO-202 for the Reduction of Central Abdominal Bulging in Obese Subjects
Central Abdominal Bulging
Phase 22015-09-01
CompletedEvaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutane
Central Abdominal Bulging
Phase 32015-04-01
UnknownAn Open-Label Study to Evaluate Retreatment With LIPO-202
Central Abdominal Bulging
Phase 22015-03-01
CompletedDose Ranging Study
Periumbilical Subcutaneous Adipose Tissue Reduction
Phase 22013-02-01
CompletedDose-ranging Study
Abdominal Contour Defects
Phase 22011-08-01
CompletedA Dose-ranging, Study of the Safety and Efficacy of Subcutaneous Injections of LIPO-102 Compared With Placebo
Weight
Phase 22010-04-01
CompletedAn Evaluation of the Safety and Efficacy of LIPO-102 for the Reduction of Subcutaneous Abdominal Adiposity
Subcutaneous Abdominal Adiposity
Phase 22009-10-01
CompletedPilot Study to Determine Safety and Efficacy of Orbital Injections of LIPO-102 in Patients With Symptomatic Ex
Thyroid-Related Eye Disease
Phase 22009-09-01
CompletedDose Ranging and Dose Frequency of LIPO-102
Subcutaneous Adipose Tissue Reduction
Phase 22009-06-01
CompletedAn Evaluation of the Pharmacokinetics and Safety of LIPO-102 in Healthy Volunteers
Subcutaneous Adipose Tissue Reduction
Phase 12009-02-01